FOXO Transcription Factors: A Brief Overview
Wolfgang Link1, Bibiana I Ferreira2,3
1Department of Cancer Biology, Sols-Morreale Biomedical Research Institute (IIBM), Spanish National Research Council (CSIC), Universidad Autónoma de Madrid (UAM), Madrid, Spain. walink@iib.uam.es.
Abstract:
Forkhead box O (FOXO) transcription factors constitute a mammalian family of proteins, comprising FOXO1, FOXO3, FOXO4, and FOXO6. Originally recognized as downstream regulators within the insulin pathway, FOXO factors exhibit the ability to bind to diverse target gene promoters, thereby governing crucial facets of cellular homeostasis. These encompass cellular energy generation, resilience against oxidative stress, and the modulation of cell viability and proliferation. The dysregulation of FOXO proteins has been established as pivotal in metabolic disorders, human longevity, and the inhibition of tumorigenesis. Notably subject to posttranslational modifications for regulation, FOXO inactivation predominantly arises from excessive activation of their upstream modifying enzymes, presenting a plethora of potential avenues for pharmaceutical reinstatement of FOXO activity.
Insights
Forkhead box O (FOXO) transcription factors regulate cellular homeostasis and are implicated in metabolic disorders and cancer. Pharmaceutical strategies aim to restore FOXO activity, offering therapeutic potential.
Area of Science:
- Molecular Biology
- Cellular Biology
- Genetics
Background:
- Forkhead box O (FOXO) transcription factors (FOXO1, FOXO3, FOXO4, FOXO6) are key regulators of cellular homeostasis.
- Initially identified in insulin signaling, FOXOs control energy metabolism, oxidative stress resistance, cell viability, and proliferation.
- Dysregulation of FOXO proteins is linked to metabolic disorders, longevity, and tumorigenesis.
Purpose of the Study:
- To summarize the role of FOXO transcription factors in cellular homeostasis.
- To highlight the involvement of FOXO dysregulation in various diseases.
- To explore the therapeutic potential of restoring FOXO activity.
Main Methods:
- Review of existing literature on FOXO transcription factors.
- Analysis of FOXO's role in cellular processes and disease pathways.
- Investigation of regulatory mechanisms, including posttranslational modifications.
Main Results:
- FOXO factors bind to target gene promoters, influencing critical cellular functions.
- FOXO dysregulation is a significant factor in metabolic diseases and cancer development.
- Posttranslational modifications are crucial for FOXO regulation, with inactivation often linked to upstream enzyme activity.
Conclusions:
- Restoring FOXO activity presents a promising therapeutic strategy for various conditions.
- Understanding FOXO regulation is vital for developing novel pharmaceutical interventions.
- Targeting FOXO pathways could offer new avenues for treating metabolic disorders and cancer.
More Related Videos
06:08Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
09:58Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Related Concept Videos
General Transcription Factors
Transcription Factors
Master Transcription Regulators
RNA Polymerase II Accessory Proteins
Co-activators and Co-repressors
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
